BLAINJECTIONINJECTABLE
Approved
Aug 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
GENOTROPIN PRESERVATIVE FREE (somatropin) by Pfizer is vitro, preclinical, and clinical tests have demonstrated that genotropin lyophilized powder is therapeutically equivalent to human growth hormone of pituitary origin and achieves similar pharmacokinetic profiles in normal adults. Approved for growth hormone deficiency, growth hormone disorder, turner syndrome and 2 more indications. First approved in 1995.
Drug data last refreshed 21h ago
Mechanism of Action
vitro, preclinical, and clinical tests have demonstrated that GENOTROPIN lyophilized powder is therapeutically equivalent to human growth hormone of pituitary origin and achieves similar pharmacokinetic profiles in normal adults. In pediatric patients who have growth hormone deficiency (GHD), have…
Indications (5)
Worked on GENOTROPIN PRESERVATIVE FREE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.